Prof. Marc Mansour advises Peptone on clinical oncology and collaborates with the company on c-Myc mechanism of action and disease-relevant models. A physician-scientist at UCL, he studies T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia, following medical training in Edinburgh and London and research experience at Harvard Medical School and Dana-Farber Cancer Institute.
Scientific Advisor for Clinical Oncology